Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and...
Neurology
CEFALY Marks a Milestone: #1 Neuromodulation Device Prescribed by Veterans Health Administration Providers
DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the...
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
Agreements formalize research partnership combining InterCure’s global pharmaceutical platform with Cannasoul’s world-class analytics and scientific innovation Collaboration comes amidst reports...
Bausch Health Announces Third Quarter 2025 Results
Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis...
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN:...
Clinical Trials Market Growing at 6.51% CAGR to 2030 Driven by Hybrid and Decentralized Trial Adoption | Mordor Intelligence Forecast
HYDERABAD, India, Oct. 28, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global clinical trials market is valued at USD 90.1...
Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- CB Insights named Sevaro Health to its seventh annual Digital Health 50,...
Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience
ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service...
Queen Square Imaging Centre: New technique could improve outcomes for essential tremor patients
BILLINGSHURST, England, Oct. 27, 2025 /PRNewswire/ -- A new study by world-leading neurosurgeons Queen Square Imaging Centre in London has...
Remedy Robotics and Mission Thrombectomy Announce Partnership to Expand Access to Thrombectomy for Stroke with Telerobotics
Remedy Robotics selected as Mission Thrombectomy's exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and...
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling...
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling...
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling...
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continued progression of joint programs...
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that...
Medical Device Market Surges to USD 750 Billion by 2033, Propelled by 5.5% CAGR – Verified Market Reports®
The Medical Device Market is witnessing robust expansion driven by rising healthcare expenditure, growing prevalence of chronic diseases, and accelerating...
Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers
IND opening marks culmination of partnership between Dewpoint and Evotec, advancing a de novo development candidate through IND-enabling studiesFirst patient...
Medical Specialists of the Palm Beaches Unveils State-of-the-Art Medical Facility in Wellington, Florida
WELLINGTON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Medical Specialists of the Palm Beaches (MSPB), a primary care-focused, multi-specialty physician...
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of...
From Signals to Strategy: The Next Chapter of Digital Biomarkers, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain a strategic lens for building durable, scalable digital biomarker programs that deliver clinical and business...